Compound Reference

CJC-1295 without DAC

Mod GRF 1-29 — Short-acting GHRH Analogue

CJC-1295 without DAC molecular structure
Molecular structure — illustrative reference.

Class

Mod GRF 1-29 — Short-acting GHRH Analogue

Molecular Weight

3,367.9 Da

Half-life

~30 minutes

Purity

≥98% (HPLC)

Form

Lyophilized powder

Storage

Lyophilized: −20°C; Reconstituted: 4°C

Reconstitution

Bacteriostatic water

Mechanism of action

CJC-1295 without DAC (Modified GRF 1-29) is a 29-amino-acid GHRH fragment with four stabilizing amino acid substitutions that improve enzyme resistance compared to native GHRH 1-29. Without the DAC moiety, it does not bind albumin and has a half-life of ~30 minutes, enabling timed pulsatile GHRH stimulation that closely mimics the physiological pattern of endogenous GH secretion.

⚠️ For Research Use Only — described exclusively for in vitro and laboratory research by qualified researchers. Not for human or veterinary use. Informational only; does not constitute medical advice or imply efficacy in humans.

Research highlights

~30 min

Half-life — mimics physiological GHRH pulsatility

Pulsatile

Natural GH secretion pattern preserved

Low

Receptor desensitization risk vs continuous dosing

+Ipam

Classic pulsatile stack with Ipamorelin

Research notes

  • Pulsatile design: Short half-life allows precise timing of GH pulses, useful for studying circadian and sleep-associated GH secretion.
  • vs DAC version: Lacks the persistent IGF-1 elevation; allows cleaner measurement windows in research protocols.
  • Minimal desensitization: Pulsatile use avoids chronic GHS-R1a downregulation concerns associated with DAC version.
  • Synergy: Standard pairing with Ipamorelin for combined GHRH + GHRP action; well-documented amplification.

For Qualified Researchers

Have a question about a compound?

Reach our team for reference details, lot documentation, or general inquiries. We respond to qualified researchers and laboratory professionals.